Edwards Lifesciences Corp (EW)
Interest coverage
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 1,618,700 | 1,748,500 | 1,690,300 | 897,600 | 1,146,800 |
Interest expense | US$ in thousands | 17,600 | 19,200 | 18,400 | 15,800 | 20,700 |
Interest coverage | 91.97 | 91.07 | 91.86 | 56.81 | 55.40 |
December 31, 2023 calculation
Interest coverage = EBIT ÷ Interest expense
= $1,618,700K ÷ $17,600K
= 91.97
The interest coverage ratio for Edwards Lifesciences Corp was not available for the years ending December 31, 2023, and December 31, 2020. However, in 2021, the company reported a high interest coverage ratio of 1,592.60, indicating a strong ability to cover its interest expenses with its operating profits. The lack of data for the other years hinders a comprehensive trend analysis of the company's interest coverage ratio over the period. It would be beneficial to obtain additional data to assess the company's financial stability and ability to meet its debt obligations.
Peer comparison
Dec 31, 2023
Company name
Symbol
Interest coverage
Edwards Lifesciences Corp
EW
91.97
Align Technology Inc
ALGN
301.47
Avanos Medical Inc
AVNS
-2.99
Intuitive Surgical Inc
ISRG
—
MSA Safety
MSA
5.42
STERIS plc
STE
4.66
Zimmer Biomet Holdings Inc
ZBH
6.54